- Home
- PAI vs TTRX Comparison
PAI vs TTRX Comparison
Compare PAI & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAI | TTRX |
|---|---|---|
| Founded | 1973 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 116.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PAI | TTRX |
|---|---|---|
| Price | $12.18 | $3.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 15.5K | 13.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.41 | $2.57 |
| 52 Week High | $13.22 | $5.98 |
Technical Indicators
Market Signals| Indicator | PAI | TTRX |
|---|---|---|
| Relative Strength Index (RSI) | 27.76 | 49.36 |
| Support Level | $12.10 | $3.55 |
| Resistance Level | $12.61 | $4.01 |
| Average True Range (ATR) | 0.13 | 0.19 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 4.94 | 44.12 |
Price Performance
Historical ComparisonAbout PAI Western Asset Investment Grade Income Fund Inc.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.
About TTRX Turn Therapeutics Inc.
Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.